---
document_datetime: 2025-09-03 09:58:10
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/yeytuo-epar-all-authorised-presentations_en.pdf
document_name: yeytuo-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7361816
conversion_datetime: 2025-12-17 14:22:44.317408
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number                    | (Invented) name   | Strength      | Pharmaceutical Form                       | Route of Administration   | Immediate Packaging        | Content (concentration)   | Pack size                                                                   |
|-----------------------------------|-------------------|---------------|-------------------------------------------|---------------------------|----------------------------|---------------------------|-----------------------------------------------------------------------------|
| EU/1/25/1976/001 EU/1/25/1976/002 | Yeytuo Yeytuo     | 300 mg 464 mg | Film-coated tablet Solution for injection | Oral use Subcutaneous use | bottle (HDPE) vial (glass) | 1.5 ml (309 mg/ml)        | 4 tablets 2 vials + 2 syringes + 2 withdrawal needles + 2 injection needles |